| IXC Stock | | | 0.07 0.01 7.46% |
Invex Therapeutics financial indicator trend analysis is infinitely more than just investigating Invex Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Invex Therapeutics is a good investment. Please check the relationship between Invex Therapeutics Non Current Liabilities Total and its Common Stock Total Equity accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Non Current Liabilities Total vs Common Stock Total Equity
Non Current Liabilities Total vs Common Stock Total Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Invex Therapeutics Non Current Liabilities Total account and
Common Stock Total Equity. At this time, the significance of the direction appears to have weak relationship.
The correlation between Invex Therapeutics' Non Current Liabilities Total and Common Stock Total Equity is 0.35. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Common Stock Total Equity in the same time period over historical financial statements of Invex Therapeutics, assuming nothing else is changed. The correlation between historical values of Invex Therapeutics' Non Current Liabilities Total and Common Stock Total Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Invex Therapeutics are associated (or correlated) with its Common Stock Total Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Total Equity has no effect on the direction of Non Current Liabilities Total i.e., Invex Therapeutics' Non Current Liabilities Total and Common Stock Total Equity go up and down completely randomly.
Correlation Coefficient | 0.35 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Non Current Liabilities Total
Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.
Most indicators from Invex Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Invex Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Issuance Of Capital Stock is likely to gain to about 10
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 1.1
M in 2024.
Invex Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Invex Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Invex Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Invex Stock Analysis
When running Invex Therapeutics' price analysis, check to
measure Invex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invex Therapeutics is operating at the current time. Most of Invex Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Invex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invex Therapeutics' price. Additionally, you may evaluate how the addition of Invex Therapeutics to your portfolios can decrease your overall portfolio volatility.